Sources also say that the administration plans to split CBER in two, with one of the section focused entirely on vaccines.

Prasad, a longtime critic of the FDA’s leniency in drug approvals, joined the agency in May. WASHINGTON — The Food and Drug ...

Vinay Prasad’s ouster as the Food and Drug Administration’s top vaccine and gene therapy regulator came after frustration ...

The U.S. Food and Drug Administration should allow patients with life-threatening diseases to access promising but not fully ...

Loomer’s outsized influence with the president came under heightened scrutiny in April after she reportedly encouraged him to ...

The FDA has denied that it plans to combine the Center for Drug Evaluation and Research and Center for Biologics Evaluation ...

Far-right provocateur Laura Loomer is crowdsourcing help to get more officials she deems disloyal to President Donald Trump ...

In a striking bipartisan move, the Senate Appropriations Committee voted 26-3 to boost the NIH’s budget by $400 million — rejecting the Trump administration’s proposed $17 billion cut and sweeping ...

Dr George Tidmarsh, a former pharmaceutical executive who joined the FDA this month, will take over Prasad’s role temporarily.

Loomer, who seems to enjoy ready access to the president’s ear, on Thursday unveiled a tip line to help fire more Trump ...

Two major health agencies are facing leadership reshuffles, with the resignations of the FDA’s Vinay Prasad and NICE’s Dr Sam Roberts.